Problem statement: Answer the multiple choice question.
Query: Which compound exhibits a 6.416% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a O=C1NN=C(c2ccccc2)CC1c1c[nH]c2ccccc12
b CC(C)(C)NC(=O)NC(=O)COC(=O)CNS(=O)(=O)c1ccc(Br)cc1Cl
c COc1ccccc1NC(=O)CSc1nc2sc(C)c(C)c2c(=O)n1C
Answer: c. COc1ccccc1NC(=O)CSc1nc2sc(C)c(C)c2c(=O)n1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccccc1NC(=O)CSc1nc2sc(C)c(C)c2c(=O)n1C
COc1ccccc1NC(=O)CSc1nc2sc(C)c(C)c2c(=O)n1C
N-(2-methoxyphenyl)-2-(3,5,6-trimethyl-4-oxothieno[2,3-d]pyrimidin-2-yl)sulfanylacetamide